The parent company of Teva, Ugg, Sanuk and other brands reported a lower loss than expected for the second quarter ended June 30. It amounted to $20.1 million, up from $7.5 million in the same period a year ago, on 13.1 percent higher overall revenues of $174.4 million.
Register a free account or login to unlock 3 more articles each week
SIGN-IN if you are already a subscriber of SGI Europe.

Already a subscriber? Sign in
Ready for unlimited coverage?
Upgrade to Professional or Premium for unlimited access to exclusive reports,
C-suite interviews, market analysis, and industry-wide research—with team licensing included.
Already registered? Sign in here